SOLSITAR (epoprostenol sodium) 1.5MG POWDER AND SOLVENT FOR PREPARING SOLUTION FOR INFUSION

SOLSITAR (epoprostenol sodium) 1.5MG POWDER AND SOLVENT FOR PREPARING SOLUTION FOR INFUSION
Product Description

EPOPROSTENOL SODIUM 1.5MG LYOPHILISED POWDER FOR IV INJECTION (1 VIAL)
In pulmonary arterial hypertension, it is indicated for improving exercise capacity in patients with WHO Functional Class III-IV symptoms of pulmonary arterial hypertension (PAH) (idiopathic or heritable PAH and PAH associated with connective tissue diseases).

FARMATEK iLAC SAN. Ve TIC. AS.

  • TR
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Pharmaceutical company
Primary activities
Contract Manufacturer
End-product distributor (Wholesale)
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Specifications
  • CAS Registry Number
    61849-14-7

FARMATEK iLAC SAN. Ve TIC. AS.

  • TR
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Pharmaceutical company
Primary activities
Contract Manufacturer
End-product distributor (Wholesale)
Out-licensing specialist
Pharmaceutical Company (generic finished products)

More Products from FARMATEK iLAC SAN. Ve TIC. AS. (29)

  • PRIDESMO (desmopressin acetate) 60MCG & 120MCG SUBLINGUAL TABLET

    Product PRIDESMO (desmopressin acetate) 60MCG & 120MCG SUBLINGUAL TABLET

    DESMOPRESSIN ACETATE 60 MCG & 120 MCG SUBLINGUAL TABLET (30 TABS)
    In the treatment of primary nocturnal enuresis, starting from the age of 5 in patients who can concentrate urine normally, • For symptomatic treatment of nocturia associated with nocturnal polyuria in adults (e.g., excessive noctur...
  • PSORETIN (acitretin) 10 MG & 25 MG SOLID CAPSULE

    Product PSORETIN (acitretin) 10 MG & 25 MG SOLID CAPSULE

    ACITRETINE 10 MG & 25 MG CAPSULE (100 CAPS)
    Used in severe extensive psoriasis resistant to other treatment modalities (topical therapy, phototherapy) in elderly patients, obese patients, and pediatric age group. It is used in severe extensive psoriasis in patients outside these groups.
    • P...
  • PULMOLIN (iloprost) 20 MCG/ML IV SOLUTION FOR INFUSION

    Product PULMOLIN (iloprost) 20 MCG/ML IV SOLUTION FOR INFUSION

    ILOPROST 20 MCG/ML SOLUTION FOR IV INFUSION (1 AMP / 5 AMPS)
  • REKSIVA (remifentanil hydrochloride) 2 MG & 5 MG POWDER FOR PREPARING SOLUTION FOR INFUSION

    Product REKSIVA (remifentanil hydrochloride) 2 MG & 5 MG POWDER FOR PREPARING SOLUTION FOR INFUSION

    REMIFENTANIL HCl 2 MG & 5 MG LYOPHILISED POWDER (5 VIALS)

    REKSIVA is used for analgesia during the induction and/or continuation of general anesthesia under close supervision. It is indicated for providing analgesia and sedation in mechanically ventilated intensive care patients aged 18 yea...
  • SEVAREN (sevelamer carbonate) 800 MG FILM TABLET

    Product SEVAREN (sevelamer carbonate) 800 MG FILM TABLET

    SEVELAMER CARBONATE 800 MG FILM COATED TABLET
    SEVAREN is indicated for the control of hyperphosphatemia in adult patients receiving hemodialysis or peritoneal dialysis.

    SEVAREN is also indicated for the control of hyperphosphatemia in adult chronic kidney disease patients not un...
  • SOLIRON (solifenacin succinate) 5MG & 10MG FILM TABLET

    Product SOLIRON (solifenacin succinate) 5MG & 10MG FILM TABLET

    SOLIFENACIN SUCCINATE 5 MG & 10 MG FILM COATED TABLET (30 TABS)
    Increased frequency of urination, severe urgency, and/or urge-type incontinence, which can be observed in patients with overactive bladder syndrome, warrant symptomatic treatment.
  • TACROLIN (tacrolimus monohydrate) 0.03% & 0.1% OINTMENT

    Product TACROLIN (tacrolimus monohydrate) 0.03% & 0.1% OINTMENT

    TACROLIMUS MONOHYDRATE 0.03% & 0.1% OINTMENT (30GR TUBE)
    TACROLIN 0.03% ointment is indicated for use in adults, adolescents aged 16 years and above, and children aged 2 years and above.
    Treatment of flare-ups: In adults and adolescents (aged 16 years and above) with moderate to severe a...
  • TANSIPREX (enalapril maleate/lercanidipine hydrochloride) 20MG/10MG FILM COATED TABLET

    Product TANSIPREX (enalapril maleate/lercanidipine hydrochloride) 20MG/10MG FILM COATED TABLET

    ENALAPRIL MALEATE/LERCANIDIPINE HYDROCHLORIDE 20MG/10MG FILM COATED TABLET (30 TABS / 90 TABS)
    The treatment of essential hypertension is indicated in patients whose blood pressure cannot be sufficiently reduced with monotherapy of either enalapril or lerkanidipine.
  • TROMABAN (rivaroxaban) 15 MG & 20 MG FILM COATED TABLET

    Product TROMABAN (rivaroxaban) 15 MG & 20 MG FILM COATED TABLET

    RIVAROXABAN 15 MG & 20 MG FILM COATED TABLET (28 TABLET)
    TROMABAN is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation who have one or more risk factors such as congestive heart failure, hypertension, age ≥75, diabetes mellitus, pr...
  • VIRATIT (entecavir) 0.5MG & 1MG FILM TABLET

    Product VIRATIT (entecavir) 0.5MG & 1MG FILM TABLET

    ENTECAVIR 0.5 MG & 1M G FILM COATED TABLET (30 TABS)
    Indicated for chronic hepatitis B virus (HBV) treatment in adults (aged 16 and above) with evidence of active viral replication, consistently elevated serum alanine aminotransferase (ALT) levels, and histological evidence of active inflammation ...
  • VORENT (voriconazole) 200 MG FILM COATED TABLET

    Product VORENT (voriconazole) 200 MG FILM COATED TABLET

    VORICONAZOLE 200 MG FILM COATED TABLET (30 TABLET)

    VORENT is a broad-spectrum antifungal agent belonging to the triazole group, indicated for the treatment of the following fungal infections:

    • Treatment of invasive aspergillosis, • Treatment of candidemia in non-neutropenic patien...
  • VULGAREX (dapsone) %7,5 TOPICAL GEL

    Product VULGAREX (dapsone) %7,5 TOPICAL GEL

    DAPSONE %7.5 TOPICAL GEL (30GR TUBE)
    VULGAREX is indicated for the topical treatment of acne vulgaris patients aged 9 years and older.

FARMATEK iLAC SAN. Ve TIC. AS. resources (1)